232 related articles for article (PubMed ID: 3284838)
41. A overview of ocular leprosy after 2 decades of multidrug therapy.
Lewallen S; Courtright P
Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
[No Abstract] [Full Text] [Related]
42. Relapse rates following leprosy multidrug therapy.
Suite M
West Indian Med J; 2000 Sep; 49(3):210-1. PubMed ID: 11076211
[TBL] [Abstract][Full Text] [Related]
43. Rationale for the preventive treatment of leprosy.
Lechat MF
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S63-6. PubMed ID: 10700940
[No Abstract] [Full Text] [Related]
44. Leprosy situation in Uttar Pradesh, 1991-2005: prevalence, case-detection and other indicators over a 15-year period.
Casabianca MN
Indian J Lepr; 2006; 78(2):137-43. PubMed ID: 16927848
[No Abstract] [Full Text] [Related]
45. [The Forthcoming History of Leprosy].
Hundeiker M; Bassukas ID
Pneumologie; 2016 Dec; 70(S 02):S174-S179. PubMed ID: 27926964
[No Abstract] [Full Text] [Related]
46. Trends in new case-detection rates at the Leprosy Mission Trust India centres.
Sundar Rao PS; Jayakumar S
Indian J Lepr; 2006; 78(2):187-94. PubMed ID: 16927852
[No Abstract] [Full Text] [Related]
47. Stigma and the leprosy phenomenon: the social history of a disease in the nineteenth and twentieth centuries.
Gussow Z; Tracy GS
Bull Hist Med; 1970; 44(5):425-49. PubMed ID: 4919121
[No Abstract] [Full Text] [Related]
48. [What shall we make of the arrival of "generalized" antibiotics to anti-Hansen's therapy?].
Decazes JM
Acta Leprol; 2001-2002; 12(2):61-2. PubMed ID: 12136737
[No Abstract] [Full Text] [Related]
49. Long-term follow-up of ROM treated cases.
Alam K; Butlin CR; Pahan D; Kumar S; Chowdhury
Lepr Rev; 2007 Jun; 78(2):160. PubMed ID: 17824488
[No Abstract] [Full Text] [Related]
50. Leprosy elimination in India--so near.
Rao CK
Indian J Lepr; 2005; 77(3):207-11. PubMed ID: 16353518
[No Abstract] [Full Text] [Related]
51. Final push for elimination of leprosy in India.
Agarwal SP
Indian J Lepr; 2005; 77(3):213-5. PubMed ID: 16353519
[No Abstract] [Full Text] [Related]
52. New case-detection trends in a multi-drug therapy programme: definite reduction in sight.
Raja Rao B
Indian J Lepr; 2006; 78(2):123-36. PubMed ID: 16927847
[TBL] [Abstract][Full Text] [Related]
53. Hansen's disease and the digestive system: clinical symptoms and gastric secretory profile at baseline conditions and following maximum stimulation with pentagastrin.
Eisig JN; Zaterka S; Boyd HK; Marchese LC; Laudanna AA
Acta Leprol; 1999; 11(3):99-104. PubMed ID: 10544722
[TBL] [Abstract][Full Text] [Related]
54. Leprosy in Mexico.
Lopez Roa RI; Morris MF
Nihon Hansenbyo Gakkai Zasshi; 2006 Feb; 75(1):51-8. PubMed ID: 16562498
[TBL] [Abstract][Full Text] [Related]
55. Five-year multiple drug therapy in Bendel State leprosy control service--an overview.
Majoroh TO
Afr J Med Med Sci; 1993 Sep; 22(3):29-33. PubMed ID: 7839909
[TBL] [Abstract][Full Text] [Related]
56. Multidrug therapy in the control of leprosy. A field study.
Becx-Bleumink M
Trop Geogr Med; 1994; 46(2):109-14. PubMed ID: 8079385
[No Abstract] [Full Text] [Related]
57. Leprosy Referral Centre: an intervention critical to sustain elimination and support integration.
Samy AA
J Commun Dis; 2006 Mar; 38(1):15-23. PubMed ID: 17370686
[TBL] [Abstract][Full Text] [Related]
58. [Hansen's disease].
Goto M
Nihon Naika Gakkai Zasshi; 2002 Oct; 91(10):2899-902. PubMed ID: 12451645
[No Abstract] [Full Text] [Related]
59. Success of the WHO multidrug therapy?
Becx-Bleumink M
Trop Geogr Med; 1994; 46(2):61-4. PubMed ID: 8079392
[No Abstract] [Full Text] [Related]
60. Committee 5: workshop on epidemiology and control including field therapy of leprosy.
Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):304-6. PubMed ID: 572354
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
